Search results
Results from the WOW.Com Content Network
A result of the successful cooperation of the German Cancer Research Center with other partners is the first new building for "The National Center for Tumor Diseases" (NCT) in Heidelberg. The project was commissioned by the German Cancer Aid with 29 Million Euro, as it was officially announced at the opening celebration on November 2, 2010 ...
Over 1 million patients per year are treated at the University Hospital Heidelberg. [5] The hospital is especially renowned for the treatment of cancer.A recent innovation in the care of cancer patient is the foundation of the National Center of Tumor Diseases (NCT) in cooperation with German Cancer Research Center (DKFZ). [6]
Following completion of his doctorate (Heidelberg) and habilitation he became a university professor in Heidelberg and, at the same time, became the head of a department at the German Cancer Research Center. [1] In 1982, Franke became the president of the European Cell Biology Organization (ECBO), a post he held until 1990. [1]
Most of the dormitories and the athletic facilities of the university can be found there as well. Several independent research institutes, such as the German Cancer Research Center, Max Planck Society and its Institute for Comparative Public Law and International Law have settled there. The New Campus is also seat of several biomedical spin-off ...
The Helmholtz Association of German Research Centres (German: Helmholtz-Gemeinschaft Deutscher Forschungszentren) is the largest scientific organisation in Germany. It is a union of 18 scientific-technical and biological-medical research centers .
The Max Planck Institute for Medical Research in Heidelberg, Germany, is a facility of the Max Planck Society for basic medical research. Since its foundation, six Nobel Prize laureates worked at the Institute: Otto Fritz Meyerhof (Physiology), Richard Kuhn (Chemistry), Walther Bothe (Physics), André Michel Lwoff (Physiology or Medicine), Rudolf Mößbauer (Physics), Bert Sakmann (Physiology ...
Peter Heinrich Krammer (born in 1946) is a German immunologist and one of the directors of The National Center for Tumor Diseases (NCT), [1] as well as the head of the Division Immunogenetics [2] at the German Cancer Research Center (DKFZ) in Heidelberg. Peter H. Krammer is well known for his research and findings in apoptosis.
It is co-directed by Prof. Andreas Kulozik from the Angelika-Lautenschläger Hospital for Children and Adolescents at the University of Heidelberg, by Prof. Matthias Hentze and Dr. Wolfgang Huber (scientist) from the European Molecular Biology Laboratory, and is housed in the Otto-Meyerhof-Research Center on the Medical Campus of the University ...